A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

WHEN doctors asked Curtis Arnold-Harmer how long he’d been using cocaine, the 29-year-old was baffled. “I’ve never touched ...

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...

Public trust in a federal access program for the overdose drug Naloxone has been shaken after more than a year of shortages ...

Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...